Navigation Links
NOVA(R) Renal: A Safe Alternative to Contrast Enhanced MRA/MRI
Date:6/3/2008

Breakthrough Technology Avoids Use of Risky Gadolinium Injections

CHICAGO, June 3 /PRNewswire/ -- VasSol's introduction of NOVA(R) Renal, a gadolinium-free procedure, offers a safe alternative to the standard contrast-enhanced Magnetic Resonance Angiography (MRA) and Magnetic Resonance Imaging (MRI) scans for patients suffering from renal disease. Contrast enhanced renal MRA/MRI has traditionally required the injection of a gadolinium based agent which the FDA has linked to the occurrence of a potentially life-threatening disease, Nephrogenic Systemic Fibrosis (NSF). NOVA(R) Renal provides a comprehensive evaluation of the renal arteries without contrast or ionizing radiation.

Who's at Risk?

According to a report by the Centers for Disease Control (CDC), one in six individuals have kidney disease, threatening their renal function and putting them at greater risk when receiving a gadolinium-enhanced MRI scan.

About NOVA(R)

NOVA(R) is the first commercially available technology to measure actual blood flow rates in individual vessels using MRA/MRI scanners. The technology provides 3-D visualization of blood vessels, as well as quantitative blood flow measurements. NOVA(R) adds a new element to the traditional MRA/MRI scan by merging hemodynamic assessment with anatomic images. Non-invasive blood flow measurements with NOVA(R) provide clinicians with more information for the diagnosis and treatment of vascular disease.

About VasSol

VasSol, is founded on 12 years of multidisciplinary research and clinical work conducted at the University of Illinois at Chicago. Bringing together experts in the fields of circulatory fluid dynamics and computer modeling, VasSol developed NOVA(R), a vascular analysis technology, which helps answer the fundamental questions healthcare professionals confront when treating vascular disease: what is the severity, how is the condition best treated and what is the outcome? The VasSol mission is to shape the future of medicine by applying leading computer, engineering and medical technologies to the diagnosis, treatment and prevention of vascular disease. Further information can be found by visiting http://www.vassolinc.com


'/>"/>
SOURCE VasSol
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Advanced Instruments Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories
2. Flat carbonated drinks not an effective alternative to oral rehydration solution
3. Saline is Safe Alternative to Harmful Cough and Cold Products
4. Eastern Remedies: Alternative Treatment for the U.S. Healthcare System
5. Natural Alternatives International, Inc. Announces Third Quarter Results
6. Telemedicine a Cost-Effective Alternative to ER Visits
7. An Alternative to Medicinal Marijuana
8. An Alternative to Surgery for Treating Skin Cancer
9. Send Me An Angel(TM) Pairs Senior Citizens With Their Peers in Alternative Care
10. SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery
11. Angioplasty Proves Reasonable Alternative to Bypass Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology: